Cite
HARVARD Citation
Wang, N. et al. (2022). One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion. Clinical & experimental ophthalmology. pp. 1038-1046. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, N. et al. (2022). One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion. Clinical & experimental ophthalmology. pp. 1038-1046. [Online].